High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population

被引：2

作者：

Kockerols, Camille C. B. ^{[1
]}

Geelen, Inge G. P. ^{[2
]}

Levin, Mark-David ^{[1
]}

Janssen, Jeroen J. W. M. ^{[3
]}

Beverloo, H. Berna ^{[4
]}

Dinmohamed, Avinash G. ^{[5
,6
,7
]}

Hoogendoorn, Mels ^{[8
]}

Cornelissen, Jan J. ^{[2
]}

Westerweel, Peter E. ^{[1
]}

机构：

[1] Albert Schweitzer Hosp, Dept Internal Med, Dordrecht, Netherlands

[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands

[4] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands

[5] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands

[6] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands

[7] Univ Amsterdam, Med Ctr, Locat VUMC, Dept Hematol, Amsterdam, Netherlands

[8] Med Ctr Leeuwarden, Dept Hematol, Leeuwarden, Netherlands

来源：

HAEMATOLOGICA | 2023年 / 108卷 / 11期

关键词：

CHROMOSOME-NEGATIVE METAPHASES; CHRONIC MYELOGENOUS LEUKEMIA; PROGNOSTIC-SIGNIFICANCE; ABNORMALITIES; IMATINIB; DIAGNOSIS; CML; TRANSFORMATION; EVOLUTION; ERA;

D O I：

10.3324/haematol.2022.282447

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3156 / 3159

页数：4

共 17 条

[1] Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors [J].

Alhuraiji, Ahmad ;

Kantarjian, Hagop ;

Boddu, Prajwal ;

Ravandi, Farhad ;

Borthakur, Gautam ;

DiNardo, Courtney ;

Daver, Naval ;

Kadia, Tapan ;

Pemmaraju, Naveen ;

Pierce, Sherry ;

Garcia-Manero, Guillermo ;

Wierda, William ;

Verstovsek, Srdan ;

Jabbour, Elias ;

Cortes, Jorge .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) :84-90

[2]

ANASTASI J, 1995, LEUKEMIA, V9, P628

[3] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].

Bumm, T ;

Müller, C ;

Al-Ali, HK ;

Krohn, K ;

Shepherd, P ;

Schmidt, E ;

Leiblein, S ;

Franke, C ;

Hennig, E ;

Friedrich, T ;

Krahl, R ;

Niederwieser, D ;

Deininger, MWN .

BLOOD, 2003, 101 (05) :1941-1949

[4] Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression [J].

Clark, Richard E. ;

Apperley, Jane F. ;

Copland, Mhairi ;

Cicconi, Silvia .

BLOOD ADVANCES, 2021, 5 (04) :1102-1109

[5] Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy [J].

Cortes, JE ;

Talpaz, M ;

Giles, F ;

O'Brien, S ;

Rios, MB ;

Shan, J ;

Garcia-Manero, G ;

Faclerl, S ;

Thomas, DA ;

Wierda, W ;

Ferrajoli, A ;

Jeha, S ;

Kantarjian, HM .

BLOOD, 2003, 101 (10) :3794-3800

[6] The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells [J].

Deininger, Michael W. N. ;

Cortes, Jorge ;

Paquette, Ron ;

Park, Byung ;

Hochhaus, Andreas ;

Baccarani, Michele ;

Stone, Richard ;

Fischer, Thomas ;

Kantarjian, Hagop ;

Niederwieser, Dietger ;

Gambacorti-Passerini, Carlo ;

So, Charlene ;

Gathmann, Insa ;

Goldman, John M. ;

Smith, Douglas ;

Druker, Brian J. ;

Guilhot, Francois .

CANCER, 2007, 110 (07) :1509-1519

[7] Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV [J].

Fabarius, Alice ;

Leitner, Armin ;

Hochhaus, Andreas ;

Mueller, Martin C. ;

Hanfstein, Benjamin ;

Haferlach, Claudia ;

Goehring, Gudrun ;

Schlegelberger, Brigitte ;

Jotterand, Martine ;

Reiter, Andreas ;

Jung-Munkwitz, Susanne ;

Proetel, Ulrike ;

Schwaab, Juliana ;

Hofmann, Wolf-Karsten ;

Schubert, Joerg ;

Einsele, Hermann ;

Ho, Anthony D. ;

Falge, Christiane ;

Kanz, Lothar ;

Neubauer, Andreas ;

Kneba, Michael ;

Stegelmann, Frank ;

Pfreundschuh, Michael ;

Waller, Cornelius F. ;

Spiekermann, Karsten ;

Baerlocher, Gabriela M. ;

Lauseker, Michael ;

Pfirrmann, Markus ;

Hasford, Joerg ;

Saussele, Susanne ;

Hehlmann, Ruediger .

BLOOD, 2011, 118 (26) :6760-6768

[8] Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe [J].

Geelen, Inge G. P. ;

Thielen, Noortje ;

Janssen, Jeroen J. W. M. ;

Hoogendoorn, Mels ;

Roosma, Tanja J. A. ;

Valk, Peter J. M. ;

Visser, Otto ;

Cornelissen, Jan J. ;

Westerweel, Peter E. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (04) :367-371

[9] Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemia [J].

Geelen, Inge G. P. ;

Thielen, Noortje ;

Janssen, Jeroen J. W. M. ;

Hoogendoorn, Mels ;

Roosma, Tanja J. A. ;

Willemsen, Sten P. ;

Visser, Otto ;

Cornelissen, Jan J. ;

Westerweel, Peter E. .

HAEMATOLOGICA, 2017, 102 (11) :1842-1849

[10] Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy [J].

Gong, Zimu ;

Medeiros, L. Jeffrey ;

Cortes, Jorge E. ;

Chen, Zi ;

Zheng, Lan ;

Li, Yan ;

Bai, Shi ;

Lin, Pei ;

Miranda, Roberto N. ;

Jorgensen, Jeffrey L. ;

McDonnell, Timothy J. ;

Wang, Wei ;

Kantarjian, Hagop M. ;

Hu, Shimin .

BLOOD ADVANCES, 2017, 1 (26) :2541-2552

← 1 2 →